
|Articles|March 31, 2020
COVID-19: Business update on Novartis operations
Author(s)Alex Delaney-Gesing
Advertisement
Patrick Mooney, vice president and head of Ophthalmology Franchise (US) at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
Recognizing biomarkers of Alzheimer Disease using OCTA
3
Midyear cataract check-in: What 2026 has brought to the OR and beyond
4
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
5





















